Exposure to selenium, and particularly to its inorganic forms, has been hypothesized as a risk factor for amyotrophic lateral sclerosis (ALS), a fast progressing motor neuron disease with poorly understood etiology. However, no information is known about levels of inorganic and some organic selenium species in the central nervous system of ALS patients, and recent observations suggest that peripheral biomarkers of exposure are unable to predict these levels for several Se species including the inorganic forms. Using a hospital-referred case-control series and advanced selenium speciation methods, we compared the chemical species of selenium in cerebrospinal fluid from 38 ALS patients to those of 38 reference neurological patients matched on age and gender. We found that higher concentrations of inorganic selenium in the form of selenite and of human serum albumin-bound selenium were associated with increased ALS risk (relative risks 3.9 (95% confidence interval 1.2-11.0) and 1.7 (1.0-2.9) for 0.1μg/L increase). Conversely, lower concentrations of selenoprotein P-bound selenium were associated with increased risk (relative risk 0.2 for 1μg/L increase, 95% confidence interval 0.04-0.8). The associations were stronger among cases age 50 years or older, who are postulated to have lower rates of genetic disease origin. These results suggest that excess selenite and human serum albumin bound-selenium and low levels of selenoprotein P-bound selenium in the central nervous system, which may be related, may play a role in ALS etiology.

Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite / Vinceti, Marco; Solovyev, N; Mandrioli, Jessica; Crespi, Cm; Bonvicini, Francesca; Arcolin, Elisa; Georgoulopoulou, Eleni; Michalke, B.. - In: NEUROTOXICOLOGY. - ISSN 0161-813X. - STAMPA. - 38:(2013), pp. 25-32. [10.1016/j.neuro.2013.05.016]

Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

VINCETI, Marco;MANDRIOLI, Jessica;BONVICINI, Francesca;Arcolin, Elisa;GEORGOULOPOULOU, Eleni;
2013

Abstract

Exposure to selenium, and particularly to its inorganic forms, has been hypothesized as a risk factor for amyotrophic lateral sclerosis (ALS), a fast progressing motor neuron disease with poorly understood etiology. However, no information is known about levels of inorganic and some organic selenium species in the central nervous system of ALS patients, and recent observations suggest that peripheral biomarkers of exposure are unable to predict these levels for several Se species including the inorganic forms. Using a hospital-referred case-control series and advanced selenium speciation methods, we compared the chemical species of selenium in cerebrospinal fluid from 38 ALS patients to those of 38 reference neurological patients matched on age and gender. We found that higher concentrations of inorganic selenium in the form of selenite and of human serum albumin-bound selenium were associated with increased ALS risk (relative risks 3.9 (95% confidence interval 1.2-11.0) and 1.7 (1.0-2.9) for 0.1μg/L increase). Conversely, lower concentrations of selenoprotein P-bound selenium were associated with increased risk (relative risk 0.2 for 1μg/L increase, 95% confidence interval 0.04-0.8). The associations were stronger among cases age 50 years or older, who are postulated to have lower rates of genetic disease origin. These results suggest that excess selenite and human serum albumin bound-selenium and low levels of selenoprotein P-bound selenium in the central nervous system, which may be related, may play a role in ALS etiology.
38
25
32
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite / Vinceti, Marco; Solovyev, N; Mandrioli, Jessica; Crespi, Cm; Bonvicini, Francesca; Arcolin, Elisa; Georgoulopoulou, Eleni; Michalke, B.. - In: NEUROTOXICOLOGY. - ISSN 0161-813X. - STAMPA. - 38:(2013), pp. 25-32. [10.1016/j.neuro.2013.05.016]
Vinceti, Marco; Solovyev, N; Mandrioli, Jessica; Crespi, Cm; Bonvicini, Francesca; Arcolin, Elisa; Georgoulopoulou, Eleni; Michalke, B.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0161813X13000934-main.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 498.06 kB
Formato Adobe PDF
498.06 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/962693
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 87
social impact